Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Weissinger

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nuklearmedizin. Nuclear Medicine|November 12, 2019
Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflowMatthias Weissinger, Jürgen Kupferschläger, Christian La Fougère, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Variability of Metabolic Rate and Distribution Volume Quantification in Whole-Body Parametric PATLAK [<sup>18</sup>F]-FDG PET/CT-A Prospective Trial in Patients with Lung CancerStephan Ursprung, Lars Zender, Patrick Ghibes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
The Prognostic Value of Quantitative Bone SPECT/CT Before <sup>223</sup>Ra Treatment in Metastatic Castration-Resistant Prostate CancerHelmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2023
Dual-Time-Point Posttherapy <sup>177</sup>Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients' OutcomeManuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver TumorsHelmut Dittmann, Daniel Kopp, Juergen Kupferschlaeger, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI StudyChristian Philipp Reinert, Cecilia Liang, Matthias Weissinger, et al.
Biomed Research International|February 14, 2018
Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer PatientsFrancesco Fiz, Samine Sahbai, Cristina Campi, et al.
European Journal of Radiology|November 18, 2024
Diagnostic performance of Photon-counting CT angiography in peripheral artery disease compared to DSA as gold standardPatrick Ghibes, Florian Hagen, Matthias Weissinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2021
Lymph Node Staging with a Combined Protocol of <sup>18</sup>F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical CarcinomaMatthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, et al.
Cancers|June 26, 2019
Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT ImagesFrancesco Fiz, Helmut Dittmann, Cristina Campi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nuklearmedizin. Nuclear Medicine|November 12, 2019
Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflowMatthias Weissinger, Jürgen Kupferschläger, Christian La Fougère, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Variability of Metabolic Rate and Distribution Volume Quantification in Whole-Body Parametric PATLAK [<sup>18</sup>F]-FDG PET/CT-A Prospective Trial in Patients with Lung CancerStephan Ursprung, Lars Zender, Patrick Ghibes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
The Prognostic Value of Quantitative Bone SPECT/CT Before <sup>223</sup>Ra Treatment in Metastatic Castration-Resistant Prostate CancerHelmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2023
Dual-Time-Point Posttherapy <sup>177</sup>Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients' OutcomeManuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver TumorsHelmut Dittmann, Daniel Kopp, Juergen Kupferschlaeger, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI StudyChristian Philipp Reinert, Cecilia Liang, Matthias Weissinger, et al.
Biomed Research International|February 14, 2018
Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer PatientsFrancesco Fiz, Samine Sahbai, Cristina Campi, et al.
European Journal of Radiology|November 18, 2024
Diagnostic performance of Photon-counting CT angiography in peripheral artery disease compared to DSA as gold standardPatrick Ghibes, Florian Hagen, Matthias Weissinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2021
Lymph Node Staging with a Combined Protocol of <sup>18</sup>F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical CarcinomaMatthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, et al.
Cancers|June 26, 2019
Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT ImagesFrancesco Fiz, Helmut Dittmann, Cristina Campi, et al.
Pageof 2